Christopher E. Diamantis - 27 Aug 2021 Form 4 Insider Report for Rennova Health, Inc.

Role
10%+ Owner
Signature
/s/ Christopher E. Diamantis
Issuer symbol
N/A
Transactions as of
27 Aug 2021
Net transactions value
$0
Form type
4
Filing time
27 Sep 2021, 17:15:35 UTC
Next filing
30 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNVA Common Stock Other +95,000,000 +21111% 95,450,000 27 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNVA Warrants to Purchase Common Stock Other +47,500,000 47,500,000 27 Aug 2021 Common Stock 47,500,000 $0.007000 Direct F1, F2
transaction RNVA Series M Convertible Redeemable Preferred Stock Other -570 -2.7% 20,180 27 Aug 2021 Common Stock Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 27, 2021, pursuant to the terms of an Exchange Agreement with the Issuer, Mr. Diamantis exchanged 570 shares of Series M Redeemable Convertible Preferred Stock of the Issuer (the "Series M Preferred Stock") for 95,000,000 shares of Common Stock and Warrants to purchase 47,500,000 shares of Common Stock.
F2 The exercise of the Warrants and the conversion of the Series M Preferred Stock are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of August 27, 2021. The Series M Preferred Stock has no stated maturity date.
F3 The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock.